EKSO Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Ekso Bionics Holdings Inc (EKSO) is not a strong buy at the moment for a beginner investor with a long-term focus and $50,000-$100,000 available for investment. The lack of positive catalysts, weak financial performance, and absence of significant trading signals suggest that holding off on this stock is a prudent decision.
The MACD histogram is negative (-0.127) and contracting, indicating weak momentum. RSI is neutral at 58.09, and moving averages are converging, suggesting no clear trend. The stock is trading near its pivot level of 10.844, with resistance at 11.955 and support at 9.732.
NULL identified. No recent news or significant trading trends from hedge funds, insiders, or Congress.
EPS also declined by -29.47% YoY. Gross margin slightly decreased, and the stock has no recent AI Stock Picker or SwingMax signals.
In Q4 2025, revenue dropped to $3.14M (-38.31% YoY), while net income improved to -$4.67M (+36.95% YoY). EPS fell to -1.46 (-29.47% YoY), and gross margin slightly decreased to 53.22% (-0.19% YoY). Overall, financial performance shows weak growth trends.
No analyst ratings or price target changes available for EKSO.
